Inogen Inc — Director's Dealing 2017

Jan 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2017-01-17

Reporting Person: Huggenberger Raymond (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-17	Common Stock	M	5680	$16.62	Acquired	12488	Direct
2017-01-17	Common Stock	S	5677	$63.9635	Disposed	6811	Direct
2017-01-17	Common Stock	S	3	$64.96	Disposed	6808	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-17	Stock Option (right to buy)	$16.62	M	5680	Disposed	2021-03-31	Common Stock (5680)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016.

F2: Represents the weighted average share price of an aggregate total of 5,677 shares sold in the price range of $63.57 to $64.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.

F4: Previous Forms 4 indicated an incorrect expiration date.